Merz Asks UPC To Bar Viatris Generic MS Drug
By Hanna Vioque ( August 11, 2025, 7:23 PM BST) -- Pharmaceutical giant Merz has sued generic-drug maker Viatris and asked Europe's patent court for a preliminary injunction as it fights to protect a soon-to-expire patented treatment for multiple sclerosis. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.